Your Patient Notes Bowel Symptoms and Abdominal Pain. What Should You Do Next?

An Algorithmic, Case-based, Primary Care Workshop on IBS-D, IBS-C, CIC, and OIC, Featuring
the Rome IV Interactive Clinical Decision Toolkit

Release Date: June 28, 2018
Last Reviewed: June 24, 2018
Expiration Date: June 28, 2019
Time to Complete Activity:  2.0 hours

*This activity expired for credit on June 28, 2019 and is no longer available for credit

Douglas A. Drossman, MD (Chair)

President, Rome Foundation
Professor Emeritus of Medicine and Psychiatry
UNC Center for Functional GI and Motility Disorders
University of North Carolina
President, Drossman Center for Education and Practice of Biopsychosocial Patient Care, LLC
Chapel Hill, NC
Joel J. Heidelbaugh, MD, FAAFP, FACG
Clinical Professor
Departments of Family Medicine and Urology
University of Michigan Medical School
Ann Arbor, MI
Brian E. Lacy, MD, PhD
Senior Associate Consultant
Mayo Clinic
Jacksonville, FL
Susan Lucak, MD
Affiliated Assistant Professor of Clinical Medicine
Weill Cornell School of Medicine
New York, NY
This activity is provided by Paradigm Medical Communications, LLC.  

In collaboration with the Rome Foundation.  

Target Audience
This activity has been designed to address the educational needs of primary care clinicians, including internists, PAs, family physicians, and nurse practitioners (NPs), who are involved or interested in the care of patients with irritable bowel syndrome with diarrhea (IBS-D), irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC), and/or opioid-induced constipation (OIC). It may also benefit gastroenterologists and other healthcare providers who are interested in the treatment and care of patients with these gastrointestinal (GI) disorders.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
• Describe the evidence-based Rome IV criteria for the diagnosis of irritable bowel syndrome subtypes, chronic idiopathic constipation, and opioid-induced constipation.
• Develop comprehensive, evidence-based treatment approaches for patients with irritable bowel syndrome subtypes, chronic idiopathic constipation, or opioid-induced constipation from a multidimensional framework.
Table of Contents
• Welcome and Introduction
• Introduction to Rome
• Rome-based Diagnosis of FGIDs
• Evidence Informing the Use of Treatments for IBS-D, IBS-C, CIC, and OIC
• Introduction to the Rome IV Interactive Clinical Decision Toolkit
• Case-based Workshop Using the Rome IV Interactive Clinical Decision Toolkit
• Q&A
Physician Accreditation Statement
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 2.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.  Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Commercial Support
This educational activity is supported by independent medical educational grants from Allergan, Inc and Ironwood Pharmaceuticals, Inc; Salix Pharmaceuticals, Inc; and Shire.
Instructions for Participation
To receive a CME certificate of participation, you should:
• Follow instructions to register or log in with your professional information and complete the pre-activity assessment.
• View the online activity in its entirety.
• Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues email us at
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Douglas A. Drossman, MD (Chair)

Retained Consultant: AbbVie, Inc.; BioAmerica Biotech; Nestle Health Science; Salix Pharmaceuticals, Inc; Shire
Joel J. Heidelbaugh, MD
No financial relationships to disclose.
Brian Lacy, MD, PhD
Retained Consultant: Ironwood Pharmaceuticals, Inc; Salix Pharmaceuticals, Inc
Susan A. Lucak, MD
Retained Consultant: Allergan, Inc; Ironwood Pharmaceuticals, Inc; Synergy Pharmaceuticals Inc
Speakers Bureau: Allergan, Inc; Ironwood Pharmaceuticals, Inc; Synergy Pharmaceuticals Inc

Steering Committee
Lin Chang, MD

Board of Directors, Rome Foundation
Professor of Medicine
Vice-Chief, Vatche and Tamar Manounkian Division of Digestive Diseases
Co-Director, Oppenheimer Center for Neurobiology of Stress and Resilience
David Geffen School of Medicine at University of California
Los Angeles, CA
Grant/Research Support: Ardelyx
Retained Consultant: Cairn Diagnostics; IM Health Science; Napo Pharmaceuticals, Inc.; Salix Pharmaceuticals, Inc; Synergy Pharmaceuticals Inc
Speakers Bureau: Allergan, Inc; Takeda Pharmaceutical Company Ltd

William D. Chey, MD
Board of Directors, Rome Foundation
Professor of Medicine
Timothy T. Nostrant Professor of Gastroenterology and Nutrition Sciences
Division of Gastroenterology
Director, GI Physiology Laboratory
Co-director, Michigan Bowel Control Program
University of Michigan Health System
Ann Arbor, MI
Grant/Research Support: Ironwood Pharmaceuticals, Inc; Nestle Health Science; Vibrant Pharma Inc.
Patents: MyGIHealth; MyNutritionHealth
Retained Consultant: Allergan, Inc; Biomerica, Inc.; IM HealthScience; Ironwood Pharmaceuticals, Inc, Nestle Health Science; Outpost Medicine; Ritter Pharmaceuticals; Salix Pharmaceuticals, Inc/Valeant Pharmaceuticals International, Inc.
Stockholder: CONTIPHARMA; Ritter Pharmaceuticals; TrueSelf™ Foods

Meghan Huff, PA-C
Physician Assistant
Drossman Gastroenterology
Chapel Hill, NC
No financial relationships to disclose.
Johannah Ruddy, M. Ed.
Executive Director
Rome Foundation
Raleigh, NC
No financial relationships to disclose.
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.
Independent peer reviewer has no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.

Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at
© 2018 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.